These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23449533)

  • 1. The clinical impact of humoral immunity in pediatric renal transplantation.
    Chaudhuri A; Ozawa M; Everly MJ; Ettenger R; Dharnidharka V; Benfield M; Mathias R; Portale A; McDonald R; Harmon W; Kershaw D; Vehaskari VM; Kamil E; Baluarte HJ; Warady B; Li L; Sigdel TK; Hsieh SC; Dai H; Naesens M; Waskerwitz J; Salvatierra O; Terasaki PI; Sarwal MM
    J Am Soc Nephrol; 2013 Mar; 24(4):655-64. PubMed ID: 23449533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A significant role for anti-human leukocyte antigen antibodies and antibody-mediated rejection in the biopsy-for-cause population.
    Banasik M; Kościelska-Kasprzak K; Myszka M; Bartoszek D; Zabińska M; Boratyńska M; Kamińska D; Mazanowska O; Zmonarski S; Krajewska M; Hałoń A; Dawiskiba T; Nowakowska B; Klinger M
    Transplant Proc; 2014 Oct; 46(8):2613-7. PubMed ID: 25380878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
    Almeshari K; Pall A; Chaballout A; Elgamal H; Almana H; Alzayer F; Abaalkhail N; Altalhi M
    Clin Transpl; 2011; ():395-400. PubMed ID: 22755437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-human leukocyte antigens and anti-major histocompatibility complex class I-related chain A antibody expression in kidney transplantation during a four-year follow-up.
    He J; Li C; Yuan XN; Zhang JL; Li Y; Wei XD; Hou JQ
    Chin Med J (Engl); 2013; 126(15):2815-20. PubMed ID: 23924448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against MICA antigens and kidney-transplant rejection.
    Zou Y; Stastny P; Süsal C; Döhler B; Opelz G
    N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
    Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Anti-MICA Antibodies in Graft Survival of Renal Transplant Recipients of India.
    Chowdhry M; Makroo RN; Singh M; Kumar M; Thakur Y; Sharma V
    J Immunol Res; 2018; 2018():3434050. PubMed ID: 29850626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartmental localization and clinical relevance of MICA antibodies after renal transplantation.
    Li L; Chen A; Chaudhuri A; Kambham N; Sigdel T; Chen R; Sarwal MM
    Transplantation; 2010 Feb; 89(3):312-9. PubMed ID: 20145522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement-fixing antibodies against denatured HLA and MICA antigens are associated with antibody mediated rejection.
    Cai J; Terasaki PI; Zhu D; Lachmann N; Schönemann C; Everly MJ; Qing X
    Exp Mol Pathol; 2016 Feb; 100(1):45-50. PubMed ID: 26615783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of anti-HLA and anti-Major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Transplant Proc; 2007 Apr; 39(3):759-60. PubMed ID: 17445592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of major histocompatibility complex class I chain-related molecule A (MICA) antibodies in live donor renal transplantation - Indian Experience.
    Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Mehra N
    Scand J Immunol; 2020 Nov; 92(5):e12923. PubMed ID: 32593197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation.
    Cox ST; Stephens HA; Fernando R; Karasu A; Harber M; Howie AJ; Powis S; Zou Y; Stastny P; Madrigal JA; Little AM
    Hum Immunol; 2011 Oct; 72(10):827-34. PubMed ID: 21664940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients.
    Seyhun Y; Ozdilli K; Oguz F; Karahan G; Onal E; Turkmen A; Eldegez U; Nane I; Çalişkan Y; Bakkaloglu H; Carin M
    Transplant Proc; 2012; 44(6):1660-6. PubMed ID: 22841239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic antibodies--valuable prognostic factor for long term kidney allograft survival.
    Moise A; Nedelcu D; Toader A; Sora M; Tica A; Ferastraoaru DE; Constantinescu I
    J Med Life; 2010; 3(4):390-5. PubMed ID: 21254736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of circulating antibodies in a renal transplantation population: preliminary results.
    Rodríguez Ferrero ML; Arroyo D; Panizo N; Vicario JL; Balas A; Anaya F
    Transplant Proc; 2012 Nov; 44(9):2548-50. PubMed ID: 23146450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
    Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survival.
    Fernández-Fresnedo G; Pastor JM; López-Hoyos M; Ruiz JC; Zubimendi JA; Gonzalez-Cotorruelo J; Rodrigo E; De Francisco AL; Arias M
    Nephrol Dial Transplant; 2003 May; 18(5):990-5. PubMed ID: 12686676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.